Targeted expression of human CD1d in transgenic mice reveals independent roles for thymocytes and thymic APCs in positive and negative selection of Vα14i NKT cells

Journal of Immunology

Volumn 175, Issue 11, 2005, Pages 7303-7310

  Schümann, Jens ^a   Pittoni, Paola ^b   Tonti, Elena ^b   MacDonald, H Robson ^a   Dellabona, Paolo ^b   Casorati, Giulia ^b  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Switzerland)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD1D ANTIGEN; CD1D ANTIGEN VALPHA14; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CELL FUNCTION; CELL SELECTION; CONTROLLED STUDY; EX VIVO STUDY; MOUSE; NEGATIVE SELECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN VARIANT; T LYMPHOCYTE; TARGET CELL; THYMOCYTE; TRANSGENIC MOUSE;

EID: 28244501321     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.11.7303     Document Type: Article

References (31)

1. Brigl, M., and M. B. Brenner. 2004. CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 22: 817-890.
2. Kronenberg, M., and L. Gapin. 2002. The unconventional lifestyle of NKT Cells. Nat. Rev. Immunol. 2: 557-568.
3. Godfrey, D. I., K. J. Hammond, L. D. Poulton, M. J. Smyth, and A. G. Baxter. 2000. NKT cells: facts, functions and fallacies. Immunol. Today 21: 573-583.
4. Bendelac, A., M. Bonneville, and J. F. Kearney. 2001. Autoreactivity by design: innate B and T lymphocytes. Nat. Rev. Immunol. 1: 177-186.
5. Zhou, D., J. Mattner, C. Cantu III, N. Schrantz, N. Yin, Y. Gao, Y. Sagiv, K. Hudspeth, Y. P. Wu, T. Yamashita, et al. 2004. Lysosomal glycosphingolipid recognition by NKT cells. Science 306: 1786-1789.
6. + cells. J. Immunol. 164: 2412-2418.
7. Gapin, L., J. L. Matsuda, C. D. Surh, and M. Kronenberg. 2001. NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat. Immunol. 10: 971-978.
8. + CD1d-dependent precursor stage. J. Exp. Med. 195: 835-844.
9. Benlagha, K., T. Kyin, A. Beavis, L. Teyton, and A. Bendelac. 2002. A thymic precursor to the NK T cell lineage. Science 296: 553-555.
10. Gadue, P., and P. L. Stein. 2002. NK T cell precursors exhibit differential cytokine regulation and require Itk for efficient maturation. J. Immunol. 169: 2397-2406.
11. Forestier, C., S. H. Park, D. Wei, K. Benlagha, L. Teyton, and A. Bendelac. 2003. T cell development in mice expressing CD1d directed by a classical MHC class II promoter. J. Immunol. 171: 4096-4104.
12. - thymocytes by class I molecules expressed by hematopoietic cells. J. Exp. Med. 178: 901-908.
13. + thymocytes selected by MHC class I molecules. Science 263: 1774-1778.
14. + cells in the liver of mice. J. Exp. Med. 180: 699-704.
15. + T cells. J. Immunol. 171: 4105-4112.
16. + T cells by CD1-expressing cortical thymocytes. J. Exp. Med. 182: 2091-2096.
17. Chun, T., M. J. Page, L. Gapin, J. L. Matsuda, H. Xu, H. Nguyen, H. S. Kang, A. K. Stanic, S. Joyce, W. A. Koltun, et al. 2003. CD1d-expressing dendritic cells but not thymic epithelial cells can mediate negative selection of NKT cells. J. Exp. Med. 197: 907-918.
18. Voyle, R. B., F. Beermann, R. K. Lees, J. Schumann, J. Zimmer, W. Held, and H. R. MacDonald. 2003. Ligand-dependent inhibition of CD1d-restricted NKT cell development in mice transgenic for the activating receptor Ly49D. J. Exp. Med. 197: 919-925.
19. Pellicci, D. G., A. P. Uldrich, K. Kyparissoudis, N. Y. Crowe, A. G. Brooks, K. J. Hammond, S. Sidobre, M. Kronenberg, M. J. Smyth, and D. I. Godfrey. 2003. Intrathymic NKT cell development is blocked by the presence of α-galactosylceramide. Eur. J. Immunol. 33: 1816-1823.
20. Lewis, D. B., C. C. Yu, K. A. Forbush, J. Carpenter, T. A. Sato, A. Grossman, D. H. Liggitt, and R. M. Perlmutter. 1991. Interleukin 4 expressed in situ selectively alters thymocyte development. J. Exp. Med. 173: 89-100.
21. Brocker, T., M. Riedinger, and K. Karjalainen. 1997. Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J. Exp. Med. 185: 541-550.
22. Brossay, L., M. Chioda, N. Burdin, Y. Koezuka, G. Casorati, P. Dellabona, and M. Kronenberg. 1998. CD1d-mediated recognition of an α- galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J. Exp. Med. 188: 1521-1528.
23. Park, S. H., D. Guy-Grand, F. A. Lemonnier, C. R. Wang, A. Bendelac, and B. Jabri. 1999. Selection and expansion of CD8αα T cell receptor αβ intestinal intraepithelial lymphocytes in the absence of both classical major histocompatibility complex class I and nonclassical CD1 molecules. J. Exp. Med. 190: 885-890.
24. - T cells in transgenic mice. J. Immunol. 170: 2390-2398.
25. Schumann, J., R. B. Voyle, B. Y. Wei, and H. R. MacDonald. 2003. Cutting edge: influence of the TCR Vβ domain on the avidity of CD1d:α- galactosylceramide binding by invariant Vα14 NKT cells. J. Immunol. 170: 5815-5819.
26. Schwartz, A., J. Ottinger, E. Wallace, R. Poon, and E. Fernandez-Repollet. 1994. Quantitative determination of antibody binding capacity (ABC) by flow cytometry. Eur. J. Histochem. 1: 13-20.
27. + T cells in vivo. J. Immunol. 173: 4799-4805.
28. Lindquist, R. L., G. Shakhar, D. Dudziak, H. Wardemann, T. Eisenreich, M. L. Dustin, and M. C. Nussenzweig. 2004. Visualizing dendritic cell networks in vivo. Nat. Immunol. 5: 1243-1250.
29. Matsuda, J. L., L. Gapin, S. Sidobre, W. C. Kieper, J. T. Tan, R. Ceredig, C. D. Surh, and M. Kronenberg. 2002. Homeostasis of Vα14i NKT cells. Nat. Immunol. 3: 966-974.
30. Ranson, T., C. A. Vosshenrich, E. Corcuff, O. Richard, V. Laloux, A. Lehuen, and J. P. Di Santo. 2003. IL-15 availability conditions homeostasis of peripheral natural killer T cells. Proc. Natl. Acad. Sci. USA 100: 2663-2668.
31. Wei, D. G., H. Lee, S. H. Park, L. Beaudoin, L. Teyton, A. Lehuen, and A. Bendelac. 2005. Expansion and long-range differentiation of the NKT cell lineage in mice expressing CD1d exclusively on cortical thymocytes. J. Exp. Med. 202: 239-248.